#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#

Sensitization of avian pathogenic Escherichia coli to amoxicillin in vitro and in vivo in the presence of surfactin


Autoři: Jiaxu Liu aff001;  Xu Wang aff001;  Weiqi Shi aff001;  Zhuoyu Qian aff002;  Yongqiang Wang aff001
Působiště autorů: Haid Central Research Institute, Animal Husbandry and Fisheries Research Center of Guangdong Haid Group Co., Ltd, Guangzhou, China aff001;  Guangzhou Foreign Languages School, Guangzhou, China aff002
Vyšlo v časopise: PLoS ONE 14(9)
Kategorie: Research Article
doi: https://doi.org/10.1371/journal.pone.0222413

Souhrn

The purpose of this study is to assess the antibiotics adjuvant effect of surfactin for boosting the treatment effect of amoxicillin. Surfactin is used as a surfactant to mediate flux of mono-and divalent cations, such as calcium, across lipid bilayer membranes. In this study, we demonstrated that surfactin can increase the activity of amoxicillin against avian pathogenic Escherichia coli (APEC) in vitro with antimicrobial assays such as minimum inhibitory concentrations (MIC) and fractional inhibitory concentration (FIC). Additionally in the model of chick infection, surfactin exerted adjuvant effects with amoxicillin against APEC by lowering the numerical value of mortality and liver bacterial loads, and regulating the expression of inflammatory cytokines et al. We concluded that surfactin can act as a novel antimicrobial adjuvant with amoxicillin against AEPC infection in chicken.

Klíčová slova:

Medicine and health sciences – Diagnostic medicine – Prognosis – Signs and symptoms – Immune physiology – Immunology – Immune system – Innate immune system – Cytokines – Immune response – Inflammation – Pathology and laboratory medicine – Pathogens – Anatomical pathology – Histopathology – Euthanasia – Pharmacology – Drugs – Biology and life sciences – Physiology – Developmental biology – Molecular development – Microbiology – Medical microbiology – Microbial pathogens – Bacterial pathogens – Microbial control – Antimicrobials – Physical sciences – Materials science – Materials – Surfactants


Zdroje

1. Nhung NT, Chansiripornchai N, Carrique-Mas JJ. Antimicrobial Resistance in Bacterial Poultry Pathogens: A Review. Frontiers in veterinary science. 2017;4:126. Epub 2017/08/30. doi: 10.3389/fvets.2017.00126 28848739; PubMed Central PMCID: PMC5554362.

2. Marshall BM LS. Food animals and antimicrobials: impacts on human health. CLIN Microbiol Rev. 2011;24:718–33. doi: 10.1128/CMR.00002-11 21976606

3. Lutful Kabir SM. Avian colibacillosis and salmonellosis: a closer look at epidemiology, pathogenesis, diagnosis, control and public health concerns. International journal of environmental research and public health. 2010;7(1):89–114. Epub 2010/03/03. doi: 10.3390/ijerph7010089 20195435; PubMed Central PMCID: PMC2819778.

4. Abu-Basha EA. In vitro susceptibility of resistant Escherichia coli field isolates to antimicrobial combinations. The Journal of Applied Poultry Research. 2012;21(3):595–602. doi: 10.3382/japr.2011-00500

5. Braga JFV, Chanteloup NK, Trotereau A, Baucheron S, Guabiraba R, Ecco R, et al. Diversity of Escherichia coli strains involved in vertebral osteomyelitis and arthritis in broilers in Brazil. BMC veterinary research. 2016;12(1):140. Epub 2016/07/16. doi: 10.1186/s12917-016-0762-0 27417195; PubMed Central PMCID: PMC5477814.

6. Chansiripornchai N MS, Boonkhum P. Antimicrobial sensitivity of avian pathogenic Escherichia coli (APEC) isolated from chickens during 2007–2010. Thai J Vet Med. 2011;(41):519–22. doi: 10.1186/1751-0147-53-64 22136406

7. Marks LR, Clementi EA, Hakansson AP. Sensitization of Staphylococcus aureus to methicillin and other antibiotics in vitro and in vivo in the presence of HAMLET. PloS one. 2013;8(5):e63158. Epub 2013/05/08. doi: 10.1371/journal.pone.0063158 23650551; PubMed Central PMCID: PMC3641093.

8. Fadli M, Chevalier J, Saad A, Mezrioui NE, Hassani L, Pages JM. Essential oils from Moroccan plants as potential chemosensitisers restoring antibiotic activity in resistant Gram-negative bacteria. International journal of antimicrobial agents. 2011;38(4):325–30. Epub 2011/07/15. doi: 10.1016/j.ijantimicag.2011.05.005 21752605.

9. Yeh MS, Wei YH, Chang JS. Enhanced production of surfactin from Bacillus subtilis by addition of solid carriers. Biotechnology progress. 2005;21(4):1329–34. Epub 2005/08/06. doi: 10.1021/bp050040c 16080719.

10. Wu YS, Ngai SC, Goh BH, Chan KG, Lee LH, Chuah LH. Anticancer Activities of Surfactin and Potential Application of Nanotechnology Assisted Surfactin Delivery. Front Pharmacol. 2017;8:761. Epub 2017/11/11. doi: 10.3389/fphar.2017.00761 29123482; PubMed Central PMCID: PMC5662584.

11. Chen WC JR, Wei YH. Applications of a lipopeptide biosurfactant, surfactin, produced by microorganisms. Biochemical Engineering Journal. 2015;103:158–69.

12. Mates SM, Patel L, Kaback HR, Miller MH. Membrane potential in anaerobically growing Staphylococcus aureus and its relationship to gentamicin uptake. Antimicrobial agents and chemotherapy. 1983;23(4):526–30. Epub 1983/04/01. doi: 10.1128/aac.23.4.526 6859831; PubMed Central PMCID: PMC184693.

13. Shahverdi AR, Fakhimi A, Zarrini G, Dehghan G, Iranshahi M. Galbanic acid from Ferula szowitsiana enhanced the antibacterial activity of penicillin G and cephalexin against Staphylococcus aureus. Biological & pharmaceutical bulletin. 2007;30(9):1805–7. Epub 2007/09/11. doi: 10.1248/bpb.30.1805 17827745.

14. Braga LC, Leite AA, Xavier KG, Takahashi JA, Bemquerer MP, Chartone-Souza E, et al. Synergic interaction between pomegranate extract and antibiotics against Staphylococcus aureus. Canadian journal of microbiology. 2005;51(7):541–7. Epub 2005/09/22. doi: 10.1139/w05-022 16175202.

15. Goren E. Observations on experimental infection of chicks with Escherichia coli. Avian pathology: journal of the WVPA. 1978;7(2):213–24. Epub 1978/04/01. doi: 10.1080/03079457808418274 18770374.

16. Alber A, Costa T, Chintoan-Uta C, Bryson KJ, Kaiser P, Stevens MP, et al. Dose-dependent differential resistance of inbred chicken lines to avian pathogenic Escherichia coli challenge. Avian pathology: journal of the WVPA. 2018:1–33. Epub 2018/12/21. doi: 10.1080/03079457.2018.1562154 30570345.

17. Bancroft JD, Cook H. C. Manual of histological techniques and their diagnostic applications. Churchill Livingstone.London. 1999.

18. Nayak A, Dodagatta-Marri E, Tsolaki AG, Kishore U. An Insight into the Diverse Roles of Surfactant Proteins, SP-A and SP-D in Innate and Adaptive Immunity. Frontiers in immunology. 2012;3:131. Epub 2012/06/16. doi: 10.3389/fimmu.2012.00131 22701116; PubMed Central PMCID: PMC3369187.

19. Brinker KG, Garner H, Wright JR. Surfactant protein A modulates the differentiation of murine bone marrow-derived dendritic cells. American journal of physiology Lung cellular and molecular physiology. 2003;284(1):L232–41. Epub 2002/10/22. doi: 10.1152/ajplung.00187.2002 12388334.

20. Cheng G, Ueda T, Nakajima H, Nakajima A, Kinjyo S, Motojima S, et al. Suppressive effects of SP-A on ionomycin-induced IL-8 production and release by eosinophils. International archives of allergy and immunology. 1998;117 Suppl 1:59–62. Epub 1998/10/06. doi: 10.1159/000053574 9758900.

21. Wu H, Kuzmenko A, Wan S, Schaffer L, Weiss A, Fisher JH, et al. Surfactant proteins A and D inhibit the growth of Gram-negative bacteria by increasing membrane permeability. The Journal of clinical investigation. 2003;111(10):1589–602. Epub 2003/05/17. doi: 10.1172/JCI16889 12750409; PubMed Central PMCID: PMC155045.

22. Han S, Mallampalli RK. The Role of Surfactant in Lung Disease and Host Defense against Pulmonary Infections. Annals of the American Thoracic Society. 2015;12(5):765–74. Epub 2015/03/06. doi: 10.1513/AnnalsATS.201411-507FR 25742123; PubMed Central PMCID: PMC4418337.

23. Miakotina OL, McCoy DM, Shi L, Look DC, Mallampalli RK. Human adenovirus modulates surfactant phospholipid trafficking. Traffic. 2007;8(12):1765–77. Epub 2007/09/28. doi: 10.1111/j.1600-0854.2007.00641.x 17897321.

24. Haczku A, Atochina EN, Tomer Y, Chen H, Scanlon ST, Russo S, et al. Aspergillus fumigatus-induced allergic airway inflammation alters surfactant homeostasis and lung function in BALB/c mice. American journal of respiratory cell and molecular biology. 2001;25(1):45–50. Epub 2001/07/27. doi: 10.1165/ajrcmb.25.1.4391 11472974.

25. Bruce SR, Atkins CL, Colasurdo GN, Alcorn JL. Respiratory syncytial virus infection alters surfactant protein A expression in human pulmonary epithelial cells by reducing translation efficiency. American journal of physiology Lung cellular and molecular physiology. 2009;297(4):L559–67. Epub 2009/06/16. doi: 10.1152/ajplung.90507.2008 19525387; PubMed Central PMCID: PMC2770795.

26. LeVine AM, Bruno MD, Huelsman KM, Ross GF, Whitsett JA, Korfhagen TR. Surfactant protein A-deficient mice are susceptible to group B streptococcal infection. J Immunol. 1997;158(9):4336–40. Epub 1997/05/01. doi: 10.1165/ajrcmb.19.4.3254 9126996.

27. LeVine AM, Kurak KE, Wright JR, Watford WT, Bruno MD, Ross GF, et al. Surfactant protein-A binds group B streptococcus enhancing phagocytosis and clearance from lungs of surfactant protein-A-deficient mice. American journal of respiratory cell and molecular biology. 1999;20(2):279–86. Epub 1999/01/28. doi: 10.1165/ajrcmb.20.2.3303 9922219.

28. LeVine AM, Kurak KE, Bruno MD, Stark JM, Whitsett JA, Korfhagen TR. Surfactant protein-A-deficient mice are susceptible to Pseudomonas aeruginosa infection. American journal of respiratory cell and molecular biology. 1998;19(4):700–8. Epub 1998/10/08. doi: 10.1165/ajrcmb.19.4.3254 9761768.

29. LeVine AM, Gwozdz J, Stark J, Bruno M, Whitsett J, Korfhagen T. Surfactant protein-A enhances respiratory syncytial virus clearance in vivo. The Journal of clinical investigation. 1999;103(7):1015–21. Epub 1999/04/09. doi: 10.1172/JCI5849 10194474; PubMed Central PMCID: PMC408263.

30. Saif YM. DISEASES OF POULTRY, 10th edn. Blackwell, London. 2011.

31. Jeffrey JS, Singer RS, O'Connor R, Atwill ER. Prevalence of pathogenic Escherichia coli in the broiler house environment. Avian diseases. 2004;48(1):189–95. Epub 2004/04/14. doi: 10.1637/7043 15077814.


Článek vyšel v časopise

PLOS One


2019 Číslo 9
Nejčtenější tento týden
Nejčtenější v tomto čísle
Kurzy

Zvyšte si kvalifikaci online z pohodlí domova

Svět praktické medicíny 1/2024 (znalostní test z časopisu)
nový kurz

Koncepce osteologické péče pro gynekology a praktické lékaře
Autoři: MUDr. František Šenk

Sekvenční léčba schizofrenie
Autoři: MUDr. Jana Hořínková

Hypertenze a hypercholesterolémie – synergický efekt léčby
Autoři: prof. MUDr. Hana Rosolová, DrSc.

Význam metforminu pro „udržitelnou“ terapii diabetu
Autoři: prof. MUDr. Milan Kvapil, CSc., MBA

Všechny kurzy
Kurzy Podcasty Doporučená témata Časopisy
Přihlášení
Zapomenuté heslo

Zadejte e-mailovou adresu, se kterou jste vytvářel(a) účet, budou Vám na ni zaslány informace k nastavení nového hesla.

Přihlášení

Nemáte účet?  Registrujte se

#ADS_BOTTOM_SCRIPTS#